6677 logo

Anxo Pharmaceutical Co., Ltd. Stock Price

TPEX:6677 Community·NT$1.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6677 Share Price Performance

NT$18.90
0.60 (3.28%)
NT$18.90
0.60 (3.28%)
Price NT$18.90

6677 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with adequate balance sheet.

4 Risks
1 Reward

Anxo Pharmaceutical Co., Ltd. Key Details

NT$883.2m

Revenue

NT$558.5m

Cost of Revenue

NT$324.7m

Gross Profit

NT$367.1m

Other Expenses

-NT$42.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.76
36.77%
-4.79%
62.0%
View Full Analysis

About 6677

Founded
2003
Employees
n/a
CEO
Linquan Yan
WebsiteView website
www.anxo.com.tw

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroenterology, anti-infectives/anti-viruses, hemodialysis/urinary system, respiratory system/antihistamine, analgesics, and others; and injections. The company was founded in 2003 and is headquartered in Taipei, Taiwan.

Recent 6677 News & Updates

Recent updates

No updates